Conversion of drug-induced SLE-syndrome by the vasodilating agent cadralazine.
The disappearance of a drug induced SLE syndrome in a 43 year old man, was described. He replaced antihypertensive agent hydralazine by an other vasodilating agent cadralazine.
Mulder
H
H
Eudokia Hospital, Rotterdam, The Netherlands.
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D011724:Pyridazines / Q000627:therapeutic use*
D011724:Pyridazines; D006830:Hydralazine; C031877:cadralazine